Intercellular adhesion molecule-I (ICAM-I) expression correlated to inflammation

Area of Science:

• Dermatology
• Immunology
• Cell Biology

Background:

• Psoriasis is a chronic inflammatory skin condition.
• Intercellular adhesion molecule-I (ICAM-I) plays a role in immune cell adhesion and inflammation.
• The expression of ICAM-I in psoriatic lesions and its modulation by treatment are not fully understood.

Purpose of the Study:

• To investigate the presence and significance of ICAM-I on keratinocytes in psoriatic skin lesions.
• To evaluate the changes in ICAM-I expression during 8-methoxapsoralen and UVA (PUVA) treatment.
• To correlate ICAM-I expression with disease severity and immune cell infiltration.

Main Methods:

• Biopsies were taken from psoriatic skin lesions of five patients before and during PUVA treatment.
• Immunohistochemistry was used to assess ICAM-I expression on keratinocytes.
• Changes in mononuclear cell infiltrate and disease severity were also evaluated.

Main Results:

• ICAM-I was expressed on keratinocytes in psoriatic lesions.
• Responders to PUVA treatment showed reduced ICAM-I expression, decreased mononuclear cell infiltrate, and lessened disease severity.
• Patients who relapsed exhibited increased ICAM-I expression, more mononuclear cells, and worsening disease.
• HLA-DR expression on keratinocytes was variable and did not strongly correlate with disease severity.

Conclusions:

• ICAM-I expression on keratinocytes is a potential biomarker for monitoring psoriasis activity and response to PUVA treatment.
• Modulation of ICAM-I may be involved in the therapeutic effects of PUVA therapy in psoriasis.
• Further research is warranted to explore the therapeutic potential of targeting ICAM-I in psoriasis management.